Atara Biotherapeutics, Inc. (ATRA) stock
ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/30
$6.77+0.27 (+4.15%)
Close on Nov 18, 2026Market cap $67.96MP/E –Yield –
Atara Biotherapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Atara Biotherapeutics's price to book ratio was 0.7× on Apr 30, 2024, against 2.6× a year earlier. Over the last 5 years it ranged from 0.7× to 20.1×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Apr 30, 2024 | 0.7× | −16.8 |
| 2023 | Oct 31, 2023 | 17.5× | +15.8 |
| 2022 | Dec 30, 2022 | 1.7× | −2.8 |
| 2021 | Dec 31, 2021 | 4.5× | +0.2 |
| 2020 | Dec 31, 2020 | 4.3× | +1.5 |
| 2019 | Dec 31, 2019 | 2.8× | −1.1 |
| 2018 | Dec 31, 2018 | 3.9× | +3.9 |
| 2017 | Dec 29, 2017 | 0.0× | −1.5 |
| 2016 | Dec 30, 2016 | 1.5× | −0.7 |
| 2015 | Dec 31, 2015 | 2.2× | – |
See a number that looks wrong?